Solr Mobile Search

Page Title - Second Level

Publications and Digital Products

View Cart Button

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Store Navigation - Start New Search

Main page content

SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these technologies. 

Publication ID
PEP24-02-014
Publication Date

Units per Product

 

Recommend

You May Also Be Interested In